400 related articles for article (PubMed ID: 21720501)
61. Chitosan-Coated Poly(lactic-co-glycolic acid)-Diiodinated boron-Dipyrromethene Nanoparticles Improve Tumor Selectivity and Stealth Properties in Photodynamic Cancer Therapy.
Voon SH; Tiew SX; Kue CS; Lee HB; Kiew LV; Misran M; Kamkaew A; Burgess K; Chung LY
J Biomed Nanotechnol; 2016 Jul; 12(7):1431-52. PubMed ID: 29336539
[TBL] [Abstract][Full Text] [Related]
62. Prolonged anti-inflammatory action of DL-lactide/glycolide copolymer nanospheres containing betamethasone sodium phosphate for an intra-articular delivery system in antigen-induced arthritic rabbit.
Horisawa E; Hirota T; Kawazoe S; Yamada J; Yamamoto H; Takeuchi H; Kawashima Y
Pharm Res; 2002 Apr; 19(4):403-10. PubMed ID: 12033371
[TBL] [Abstract][Full Text] [Related]
63. Magnetic core-shell nanoparticles for drug delivery by nebulization.
Verma NK; Crosbie-Staunton K; Satti A; Gallagher S; Ryan KB; Doody T; McAtamney C; MacLoughlin R; Galvin P; Burke CS; Volkov Y; Gun'ko YK
J Nanobiotechnology; 2013 Jan; 11():1. PubMed ID: 23343139
[TBL] [Abstract][Full Text] [Related]
64. Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier.
Tosi G; Bortot B; Ruozi B; Dolcetta D; Vandelli MA; Forni F; Severini GM
Curr Med Chem; 2013; 20(17):2212-25. PubMed ID: 23458620
[TBL] [Abstract][Full Text] [Related]
65. PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses.
Ma W; Chen M; Kaushal S; McElroy M; Zhang Y; Ozkan C; Bouvet M; Kruse C; Grotjahn D; Ichim T; Minev B
Int J Nanomedicine; 2012; 7():1475-87. PubMed ID: 22619507
[TBL] [Abstract][Full Text] [Related]
66. Poly(lactic-co-glycolic) Acid (PLGA) Nanoparticles and Transdermal Drug Delivery: An Overview.
Kumar L; Kukreti G; Rana R; Chaurasia H; Sharma A; Sharma N; Komal
Curr Pharm Des; 2023; 29(37):2940-2953. PubMed ID: 38173050
[TBL] [Abstract][Full Text] [Related]
67. Preparation and Evaluation of Chrysin Encapsulated in PLGA- PEG Nanoparticles in the T47-D Breast Cancer Cell Line.
Mohammadinejad S; Akbarzadeh A; Rahmati-Yamchi M; Hatam S; Kachalaki S; Zohreh S; Zarghami N
Asian Pac J Cancer Prev; 2015; 16(9):3753-8. PubMed ID: 25987033
[TBL] [Abstract][Full Text] [Related]
68. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect.
Acharya S; Sahoo SK
Adv Drug Deliv Rev; 2011 Mar; 63(3):170-83. PubMed ID: 20965219
[TBL] [Abstract][Full Text] [Related]
69. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
[TBL] [Abstract][Full Text] [Related]
70. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
Dong Y; Feng SS
Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
[TBL] [Abstract][Full Text] [Related]
71. Pharmacokinetic Consequences of PLGA Nanoparticles in Docetaxel Drug Delivery.
Rafiei P; Haddadi A
Pharm Nanotechnol; 2017; 5(1):3-23. PubMed ID: 28948907
[TBL] [Abstract][Full Text] [Related]
72. Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate.
Esmaeili F; Ghahremani MH; Ostad SN; Atyabi F; Seyedabadi M; Malekshahi MR; Amini M; Dinarvand R
J Drug Target; 2008 Jun; 16(5):415-23. PubMed ID: 18569286
[TBL] [Abstract][Full Text] [Related]
73. Liver-targeting Resibufogenin-loaded poly(lactic-co-glycolic acid)-D-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy.
Chu Q; Xu H; Gao M; Guan X; Liu H; Deng S; Huo X; Liu K; Tian Y; Ma X
Int J Nanomedicine; 2016; 11():449-63. PubMed ID: 26869788
[TBL] [Abstract][Full Text] [Related]
74. A Promising Emodin-Loaded Poly (Lactic-Co-Glycolic Acid)-d-α-Tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles for Liver Cancer Therapy.
Liu H; Gao M; Xu H; Guan X; Lv L; Deng S; Zhang C; Tian Y
Pharm Res; 2016 Jan; 33(1):217-36. PubMed ID: 26334502
[TBL] [Abstract][Full Text] [Related]
75. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.
Jain RA
Biomaterials; 2000 Dec; 21(23):2475-90. PubMed ID: 11055295
[TBL] [Abstract][Full Text] [Related]
76. Glycyrrhetinic Acid-Mediated Polymeric Drug Delivery Targeting the Acidic Microenvironment of Hepatocellular Carcinoma.
Zhang J; Zhang M; Ji J; Fang X; Pan X; Wang Y; Wu C; Chen M
Pharm Res; 2015 Oct; 32(10):3376-90. PubMed ID: 26148773
[TBL] [Abstract][Full Text] [Related]
77. Development and in vitro evaluation of surface modified poly(lactide-co-glycolide) nanoparticles with chitosan-4-thiobutylamidine.
Grabovac V; Bernkop-Schnürch A
Drug Dev Ind Pharm; 2007 Jul; 33(7):767-74. PubMed ID: 17654025
[TBL] [Abstract][Full Text] [Related]
78. Bypassing multidrug resistance in human breast cancer cells with lipid/polymer particle assemblies.
Li B; Xu H; Li Z; Yao M; Xie M; Shen H; Shen S; Wang X; Jin Y
Int J Nanomedicine; 2012; 7():187-97. PubMed ID: 22275834
[TBL] [Abstract][Full Text] [Related]
79. Permeation of PLGA nanoparticles across different in vitro models.
Nkabinde LA; Shoba-Zikhali LN; Semete-Makokotlela B; Kalombo L; Swai HS; Hayeshi R; Naicker B; Hillie TK; Hamman JH
Curr Drug Deliv; 2012 Nov; 9(6):617-27. PubMed ID: 22812395
[TBL] [Abstract][Full Text] [Related]
80. Hydrophilic poly(DL-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells.
Walter E; Dreher D; Kok M; Thiele L; Kiama SG; Gehr P; Merkle HP
J Control Release; 2001 Sep; 76(1-2):149-68. PubMed ID: 11532321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]